Skip to content

SG&A at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
$613.3M+8.9%
Medtronic logo
MedtronicMDT
$3.06B+12.4%
ITG
Integer HoldingsITGR
$58.71M+14.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$118.21M+10.0%
TFX
TeleflexTFX
$226.01M+47.8%
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$65.09M+17.9%

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's SG&A?
Microbot Medical (MBOT) reported SG&A of $3.03M in Q1 2026.
How has Microbot Medical's SG&A changed year-over-year?
Microbot Medical's SG&A increased by 93.9% year-over-year, from $1.56M to $3.03M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.